|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Singh N and Gilks CB: The changing
landscape of gynaecological cancer diagnosis: Implications for
histopathological practice in the 21st century. Histopathology.
70:56–69. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tropé CG, Abeler VM and Kristensen GB:
Diagnosis and treatment of sarcoma of the uterus. A review. Acta
Oncol. 51:694–705. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ghirardi V, Bizzarri N, Guida F, Vascone
C, Constantini B, Scambia G and Fagotti A: Role of surgery in
gynaecological sarcomas. Oncotarget. 10:2561–2575. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Giuntoli RL 2nd, Metzinger DS, DiMarco CS,
Cha SS, Sloan JA, Keeney GL and Gostout BS: Retrospective review of
208 patients with leiomyosarcoma of the uterus: Prognostic
indicators, surgical management, and adjuvant therapy. Gynecol
Oncol. 89:460–469. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hoang L, Chiang S and Lee CH: Endometrial
stromal sarcomas and related neoplasms: New developments and
diagnostic considerations. Pathology. 50:162–177. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH (eds): WHO Classification of Tumours of Female
Reproductive Organs. 4th edition. IARC Press, Lyon, pp135-147,
2014.
|
|
8
|
Oliva E: Cellular mesenchymal tumors of
the uterus: A review emphasizing recent observations. Int J Gynecol
Pathol. 33:374–384. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Prat J: FIGO staging for uterine sarcomas.
Int J Gynaecol Obstet. 104:177–178. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ueda SM, Kapp DS, Cheung MK, Shin JY,
Osann K, Husain A, Teng NN, Berek JS and Chan JK: Trends in
demographic and clinical characteristics in women diagnosed with
corpus cancer and their potential impact on the increasing number
of deaths. Am J Obstet Gynecol. 198(218)2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
World Health Organization: International
Statistical Classification of Diseases and Related Health Problems
10th Revision. ICD-10 version 2015. Available at: urihttps://icd.who.int/browse10/2015/ensimplehttps://icd.who.int/browse10/2015/en.
|
|
12
|
FIGO Committee on Gynecologic Oncology.
FIGO staging for carcinoma of the vulva, cervix, and corpus uteri.
Int J Gynecol Obstet. 125:97–98. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Koivisto-Korander R, Martinsen JI,
Weiderpass E, Lemnen A and Pukkala E: Incidence of uterine
leiomyosarcoma and endometrial stromal sarcoma in nordic countries:
Results from NORDCAN and NOCCA databases. Maturitas. 72:56–60.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mbatani N, Olawaiye EA and Prat J: Uterine
sarcomas. Int J Gynecol Obstet. 143:51–58. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Felix AS, Cook LS, Gaudet MM, Rohan TE,
Schouten LJ, Setiawan VW, Wise LA, Anderson KE, Bernstein L, De
Vivo I, et al: The etiology of uterine sarcomas: A pooled analysis
of the epidemiology of endometrial cancer consortium. Br J Cancer.
108:727–734. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang YY, Li Y, Qin M, Cai Y, Jin Y and
Pan LY: High-grade endometrial stromal sarcoma: A retrospective
study of factors influencing prognosis. Cancer Manag Res.
11:831–837. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ishidera Y, Yoshida H, Oi Y, Katayama K,
Miyagi E, Hayashi H and Shigeta H: Analysis of uterine corporeal
mesenchymal tumors occurring after menopause. BMC Women Health.
19(13)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Koivisto-Korander R, Butzow R, Koivisto AM
and Leminen A: Clinical outcome and prognostic factors in 100 cases
of uterine sarcoma: Experience in helsinki university central
hospital 1990-2001. Gynecol Oncol. 111:74–81. 2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Oliva E: Practical issues in uterine
pathology from banal to bewildering: The remarkable spectrum of
smooth muscle neoplasia. Mod Pathol. 29 (Suppl 1):S104–S120.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Burghaus S, Halmen S, Gass P, Mehlhorn G,
Schrauder MG, Lux MP, Renner SP, Beckmann MW, Hein A and Thiel FC:
Outcome and prognosis in uterine sarcoma and malignant mixed
mullerian tumor. Arch Gynecol Obstet. 294:343–351. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Menczer J: Review of recommended treatment
of uterine carcinoma. Curr Treat Options Oncol.
16(53)2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nordal RR and Thoresen SO: Uterine
sarcomas in Norway 1956-1992: Incidence, survival and mortality.
Eur J Cancer. 33:907–911. 1997.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zivanovic O, Leitao MM, Iasonos A, Jacks
LM, Zhou Q, Abu-Rustum NR, Soslow RA, Juretzka MM, Chi DS, Barakat
RR, et al: Stage-specific outcomes of patients with uterine
leiomyosarcoma: A comparison of the international federation of
gynecology and obstetrics and american joint committee on cancer
staging systems. J Clin Oncol. 27:2066–2072. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wada H, Enomoto T, Fujita M, Yoshino K,
Nakashima R, Kurachi H, Haba T, Wakasa K, Shroyer KR, Tsujimoto M,
et al: Molecular evidence that most but not all carcinosarcomas of
the uterus are combination tumors. Cancer Res. 57:5379–5385.
1997.PubMed/NCBI
|
|
25
|
Nusrath S, Bafna S, Rajagopalan R,
Thammineedi SR, Raju KVV, Patnaik SC, Pawar S, Reddy Y, Chavali RN
and Murthy SS: Uterine sarcomas: Experience from a tertiary cancer
care center from India. Indian J Surg Oncol. 10:342–349.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Şükür YE, Taşkın S, Varlı B, Ateş C,
Güngör M and Ortaç F: Prognostic factors for disease-free and
overall survival of patients with uterine carcinosarcoma. Int J
Clin Oncol. 23:114–120. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bernard B, Clarke BA, Malowany JI,
McAlpine J, Lee CH, Atenafu EG, Ferguson S and Mackay H: Uterine
adenosarcomas: A dual-institution update on staging, prognosis and
survival. Gynecol Oncol. 131:634–639. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Pietzner K, Buttmann-Schweiger N, Sehouli
J and Kraywinkel K: Incidence patterns and survival of
gynecological sarcoma in Germany: Analysis of population-based
cancer registry data on 1066 women. Int J Gynecol Cancer.
28:134–138. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
D'Angelo E and Prat J: Uterine sarcomas: A
review. Gynecol Oncol. 116:131–139. 2010.PubMed/NCBI View Article : Google Scholar
|
